Overview

Detailed Summary

GPT Healthcare Limited operates a chain of multispecialty hospitals in Eastern India, focusing on providing tertiary care services. Its core business includes specialties like oncology, cardiology, and nephrology with a strong presence in cities like Kolkata, Agartala, and Raipur.
The company's revenue reached INR 350.5 Cr for 9M FY26, marking a robust year-on-year growth of 12.12%. Despite this, EBITDA margins have come under pressure, declining to 18.6%, impacted by new hospital expansions.
The launch of new facilities like the Raipur hospital, commissioned with state-of-the-art technology for renal transplants and oncology, is enhancing GPT's service offerings and scaling operations.
GPT Healthcare emphasizes technology-driven healthcare innovation, boasting a high ARPOB and integrating robotic surgeries across its hospitals, notably in Salt Lake and Howrah, reflecting its strategic focus on advanced treatments.
The company is targeting expansion to a 1,000-bed network by FY27, with plans for new hospitals in Jamshedpur and beyond, underscoring aggressive capacity growth strategy in Eastern India.

Sector: Healthcare Services
Industry: Hospital
Market Cap: 1,053 Cr
Volatility: Low Risk
P/E Ratio: 22.1
Industry P/E: 59.2
PEG Ratio: 0.7
P/B Ratio: 5.4
52W High: 184.80
52W Low: 114.00

Sales CAGR

1Y: 38.99%
3Y: 6.46%
5Y: 13.96%
10Y: —

Profit CAGR

1Y: 97.53%
3Y: 6.21%
5Y: 35.43%
10Y: —

ROE

TTM: 26.36%
3Y: 21.64%
5Y: 21.59%
10Y: —

ROCE

TTM: 23.95%
3Y: 25.89%
5Y: 24.04%
10Y: —

Technicals

‌

Forecasts

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Peers

Healthcare Healthcare Healthcare Services Hospital

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
KMCSHIL		113.80	1,856 Cr	39.71	8.82	0.00	22.21	24.22	14.07
SHALBY		169.75	1,828 Cr	48.86	1.82	0.00	3.72	6.20	1.89
GPTHEALTH		150.60	1,060 Cr	22.24	5.35	2.71	26.36	23.95	0.00
GKSL		130.00	1,017 Cr	65.63	4.03	0.00	6.14	8.20	5.65
UNIHEALTH		460.70	733 Cr	28.36	5.21	0.00	18.77	27.73	17.88
KRMAYURVED		232.05	493 Cr	24.62	4.10	0.00	17.54	26.13	16.39
ASARFI		217.95	427 Cr	25.62	4.37	0.00	17.06	16.27	8.62
Median: 7 Co.	—	169.75	1,017 Cr	28.36	4.37	0.00	17.54	23.95	8.62

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	97	99	98	106	102	101	107	119	120	126
Expenses	76	76	80	82	81	81	90	96	99	103
Operating Profit	21	23	18	23	21	21	17	23	21	23
OPM %	21.74	23.31	18.37	22.17	20.81	20.40	16.21	19.13	17.24	18.49
Other Income	1.18	1.59	2.24	2.80	1.88	1.57	1.56	1.34	1.42	1.63
Interest	1.69	1.59	0.86	0.74	0.85	1.02	1.63	2.16	2.26	2.18
Depreciation	4.50	4.76	4.68	4.80	4.67	4.88	6.18	6.85	7.11	6.95
Profit Before Tax	16	18	15	21	18	16	11	15	13	16
Tax %	28.27	30.42	32.04	28.37	30.48	21.26	30.87	29.66	26.57	8.20
Net Profit	11	13	9.96	15	12	13	7.68	11	9.37	15
EPS in Rs	—	1.59	1.21	1.81	1.49	1.57	0.94	1.29	1.14	1.78

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022
Sales	212	243	337
Expenses	176	194	264
Operating Profit	36	49	74
OPM %	16.90	20.18	21.88
Other Income	4.23	6.11	4.99
Interest	14	14	11
Depreciation	11	12	14
Profit Before Tax	15	29	54
Tax %	26.17	26.97	22.96
Net Profit	11	21	42
EPS in Rs	—	—	—
Dividend Payout %	0.00	69.44	114.94

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022
Equity Capital	18	18	80
Reserves	109	116	78
Borrowings	157	166	96
Other Liabilities	25	18	70
Total Liabilities	308	317	323
Fixed Assets	226	220	220
CWIP	1.77	0.30	0.72
Investments	0.68	0.68	10
Other Assets	80	97	92
Total Assets	308	317	323

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022
Cash from Operating Activity	41	43	66
Cash from Investing Activity	-54	-16	-5.34
Cash from Financing Activity	12	-22	-57
Net Cash Flow	-0.93	4.43	3.49

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Oct 2021	Oct 2023	Feb 2024	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	99.97%	67.34%	65.57%	65.57%	65.57%	65.57%	65.57%	65.57%	65.57%	65.57%	65.57%	65.57%
FIIs	0.00%	0.00%	7.13%	6.68%	5.38%	4.70%	4.72%	4.48%	4.96%	3.20%	2.74%	2.81%
DIIs	0.03%	32.66%	10.07%	12.81%	13.08%	11.99%	11.30%	11.35%	9.32%	6.46%	6.20%	6.83%
Public	0.00%	0.00%	17.22%	14.94%	15.96%	17.73%	18.41%	18.59%	20.15%	24.76%	25.49%	24.78%
Total Shareholders	9	9	1,27,338	76,664	71,293	74,737	70,147	68,365	67,060	67,617	66,626	64,075

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q4 FY26

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Available on Pro Plan